Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- CheckyesterdayChange DetectedDeleted items remove the drug Pembrolizumab and several lymphoma-related disease terms from the page, altering the study's described intervention and target conditions. These removals also affect how the study is indexed and understood by users seeking details about treatment and eligibility.SummaryDifference18%

- Check8 days agoChange DetectedRecruitment status now shows no further participant enrollment, and new help/navigation sections are added along with a revision update to v3.6.0; the old label formatting and prior revision tag were removed.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build. There are no changes to study details or visible content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page's revision metadata now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This is an administrative update to the page versioning rather than a change to trial data or details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s UI/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a platform release rather than a change to the study record itself.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.